Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - head+and+neck+cancer
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Bioelectric Neuromodulation Methods for Hematopoiesis Regulation During Chemotherapy (Case No. 2020-382)
Summary: UCLA researchers in the Department of Bioengineering have developed an electrical neuromodulation method to accelerate recovery from deleterious chemotherapy side effects to improve patient outcome. Background: Chemotherapy works by targeting and killing fast-growing cancer cells using anti-cancer drugs. However, because these drugs lack...
Published: 8/21/2025
|
Inventor(s):
Wentai Liu
Keywords(s):
algorithmic cancer detection
,
Bladder Cancer
,
blood cancers
,
Brain cancer
,
Breast Cancer
,
Cancer
,
cancer antigen
,
cancer detection
,
Cancer Immunotherapy
,
cancer inhibition
,
cancer metabolism
,
Cancer stem cells
,
cancer target
,
castration resistant prostate cancer
,
Chemotherapy
,
head and neck cancer
,
lympathic cancers
,
lymphatic cancer
,
Mesenchymal Stem Cell Derived Cancer Cells
,
Neuromodulation
,
non-small cell lung cancer
,
Orthotopic cancer models
,
Pancreatic cancer
,
prostate cancer
,
small cell cancer
,
small cell lung cancer
,
small cell prostate cancer
Category(s):
Medical Devices
,
Medical Devices > Neural Stimulation
,
Chemical
,
Electrical
,
Therapeutics
,
Therapeutics > Oncology
Methods To Predict the Efficacy of Neoadjuvant Anti-PD-1 Therapy in Resectable Oral-Cavity Squamous Cell Carcinoma and Target Post-Surgical Relapses (UCLA Case No. 2022-039)
UCLA researchers in the School of Medicine have developed a novel therapeutic strategy to improve prognosis of resectable
head and neck cancer
patients based on clinical studies. BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is an aggressive and recurrent cancer, ranked sixth among common epithelial malignancies worldwide. Over a third...
Published: 7/17/2025
|
Inventor(s):
Roger Lo
Keywords(s):
anti-PD-1
,
head and neck cancer
,
head and neck squamous cell carcinoma (HNSCC)
,
Immunotherapy
,
oral cavity squamous cell carcinoma (OCSCC)
,
resectable tumors
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy